001     841562
005     20210129232035.0
024 7 _ |a 10.3390/md15110359
|2 doi
024 7 _ |a 2128/17609
|2 Handle
024 7 _ |a WOS:000416600200029
|2 WOS
024 7 _ |a altmetric:29415228
|2 altmetric
024 7 _ |a pmid:29135916
|2 pmid
037 _ _ |a FZJ-2017-08600
082 _ _ |a 540
100 1 _ |a Küppers, Lisa
|0 P:(DE-HGF)0
|b 0
245 _ _ |a Lactones from the Sponge-Derived Fungus Talaromyces rugulosus
260 _ _ |a Basel
|c 2017
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1520844243_25959
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a The marine-derived fungus Talaromyces rugulosus isolated from the Mediterranean sponge Axinella cannabina and cultured on solid rice medium yielded seventeen lactone derivatives including five butenolides (1–5), seven (3S)-resorcylide derivatives (6–12), two butenolide-resorcylide dimers (13 and 14), and three dihydroisocoumarins (15–17). Among them, fourteen compounds (1–3, 6–16) are new natural products. The structures of the isolated compounds were elucidated by 1D and 2D NMR (Nuclear Magnetic Resonance) spectroscopy as well as by ESI-HRMS (ElectroSpray Ionization-High Resolution Mass Spectrometry). TDDFT-ECD (Time-Dependent Density Functional Theory-Electronic Circular Dichroism) calculations were performed to determine the absolute configurations of chiral compounds. The butenolide-resorcylide dimers talarodilactones A and B (13 and 14) exhibited potent cytotoxicity against the L5178Y murine lymphoma cell line with IC50 values of 3.9 and 1.3 µM, respectively.
536 _ _ |a 551 - Functional Macromolecules and Complexes (POF3-551)
|0 G:(DE-HGF)POF3-551
|c POF3-551
|f POF III
|x 0
700 1 _ |a Ebrahim, Weaam
|0 P:(DE-HGF)0
|b 1
700 1 _ |a El-Neketi, Mona
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Özkaya, Ferhat C.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Mándi, Attila
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Kurtán, Tibor
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Orfali, Raha S.
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Müller, Werner E. G.
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Hartmann, Rudolf
|0 P:(DE-Juel1)132001
|b 8
|u fzj
700 1 _ |a Lin, Wenhan
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Song, Weiguo
|0 P:(DE-HGF)0
|b 10
700 1 _ |a Liu, Zhen
|0 P:(DE-HGF)0
|b 11
|e Corresponding author
700 1 _ |a Proksch, Peter
|0 P:(DE-HGF)0
|b 12
|e Corresponding author
773 _ _ |a 10.3390/md15110359
|0 PERI:(DE-600)2175190-0
|p 359
|t Marine drugs
|v 15
|y 2017
|x 1660-3397
856 4 _ |y OpenAccess
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.pdf
856 4 _ |y OpenAccess
|x icon
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.gif?subformat=icon
856 4 _ |y OpenAccess
|x icon-1440
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.jpg?subformat=icon-1440
856 4 _ |y OpenAccess
|x icon-180
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.jpg?subformat=icon-180
856 4 _ |y OpenAccess
|x icon-640
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.jpg?subformat=icon-640
856 4 _ |y OpenAccess
|x pdfa
|u https://juser.fz-juelich.de/record/841562/files/Lactones%20from%20the%20Sponge-Derived%20Fungus%20Talaromyces%20rugulosus.pdf?subformat=pdfa
909 C O |o oai:juser.fz-juelich.de:841562
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 8
|6 P:(DE-Juel1)132001
913 1 _ |a DE-HGF
|b Key Technologies
|l BioSoft – Fundamentals for future Technologies in the fields of Soft Matter and Life Sciences
|1 G:(DE-HGF)POF3-550
|0 G:(DE-HGF)POF3-551
|2 G:(DE-HGF)POF3-500
|v Functional Macromolecules and Complexes
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
914 1 _ |y 2018
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MAR DRUGS : 2015
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)ICS-6-20110106
|k ICS-6
|l Strukturbiochemie
|x 0
980 1 _ |a FullTexts
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)ICS-6-20110106
981 _ _ |a I:(DE-Juel1)IBI-7-20200312


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21